menu ☰
menu ˟

Phase 3 IGNITE4 trial to examine safety, efficacy of IV eravacycline in cIAIs

19 Oct 2016
Tetraphase Pharmaceuticals recently launched IGNITE4 — a randomized, double blind, phase 3 trial examining the safety and efficacy of IV eravacycline compared with meropenem in patients with complicated intra-abdominal infections — according to a...

Click here to view the full article which appeared in Nursing

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.